Breakthrough Study Reveals Potential Risks of COVID Vaccines During Pregnancy

Top medical experts have raised concerns after discovering fibrous, prion-like clots in the blood of young children exposed to COVID-19 mRNA vaccines during pregnancy. Dr. Kevin McCairn, a renowned neuroscientist, has published findings that challenge the widely accepted notion of the vaccines' safety for expectant mothers. McCairn's study identified amyloid fibrils, misfolded proteins linked to neurodegenerative diseases, in a 3-year-old child's blood. The child was born prematurely after the mother received her second Pfizer dose, and faced severe health issues from birth, including immune dysfunction and recurring infections. Using advanced imaging techniques, the team found fibrillar structures in the child's blood, suggesting that mRNA vaccines can transfer to the fetus. This contradicts previous claims that the placenta blocks vaccine components and that fibrils require ongoing seeding to persist. Backed by leading experts, McCairn's findings highlight the need for further investigation into the long-term effects of mRNA vaccines during pregnancy. He urges a precautionary approach, emphasizing the potential for these vaccines to induce persistent amyloidogenic cascades, a scenario previously dismissed as speculative. This groundbreaking research underscores the necessity for rigorous evaluation of vaccine safety, particularly in vulnerable populations, and raises critical questions about the broader implications of mRNA technology use during pregnancy.

Published: 6/8/2025